A Delta-Sleep-Inducing Peptide (DSIP) Certificate of Analysis (COA) is an official third-party analytical report verifying batch identity, purity thresholds, and safety metrics for laboratory experimentation. PX1 Research provides lot-specific DSIP COA documentation featuring RP-HPLC purity analysis exceeding 99%, LC-MS mass identification matching the 848.81 Da theoretical molecular weight, and chromogenic endotoxin assay validation.
A Delta-Sleep-Inducing Peptide (DSIP) Certificate of Analysis (COA) is an official third-party analytical report verifying batch identity, purity thresholds, and safety metrics for laboratory experimentation. PX1 Research provides lot-specific DSIP COA documentation featuring RP-HPLC purity analysis exceeding 99%, LC-MS mass identification matching the 848.81 Da theoretical molecular weight, and chromogenic endotoxin assay validation.
In analytical chemistry and preclinical peptide evaluation, obtaining a comprehensive Certificate of Analysis (COA) is the primary requirement prior to initiating any quantitative assay. A verifiable DSIP COA documents the chemical fidelity of the synthesized nonapeptide, ensuring that experimental variables remain tightly controlled across different trial series.
When evaluating a batch of DSIP 60mg, researchers must verify multiple analytical parameters beyond baseline peptide content. A complete quality control packet issued by an independent ISO 17025 accredited laboratory includes liquid chromatography-mass spectrometry (LC-MS) structural identification, reverse-phase high-performance liquid chromatography (RP-HPLC) optical purity testing, residual solvent quantification, and bacterial endotoxin testing via Limulus Amebocyte Lysate (LAL) assays. Access to these rigorous analytical records via our peptide research library guarantees that investigators receive unadulterated research material free of synthesis side-products or truncated peptide sequences.
Mass spectrometry (MS) provides unambiguous confirmation of a peptide's primary chemical identity by measuring the mass-to-charge ratio (m/z) of ionized molecules. For Delta-Sleep-Inducing Peptide—a linear nonapeptide with the primary amino acid sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu—the theoretical monoisotopic molecular weight is precisely 848.81 g/mol.
In a standard dsip-coa mass spectrum report, the observed mass peak must align with this theoretical value within strict tolerance limits (typically ± 0.5 Da). High-resolution electrospray ionization mass spectrometry (ESI-MS) detects both the singly protonated [M+H]+ species at ~849.8 m/z and secondary adduct peaks. The absence of extraneous signal spikes outside the expected isotopic envelope confirms that the chemical structure has not suffered deamidation, oxidation, or improper side-chain deprotection during solid-phase peptide synthesis (SPPS).
While mass spectrometry establishes chemical identity, Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) quantifies overall chemical purity by separating the target peptide from synthesis byproducts, diastereomers, and short-chain deletion sequences. Analytical RP-HPLC utilizes a hydrophobic stationary phase (such as a C18 silica column) and a gradient mobile phase composed of acetonitrile and water with 0.1% trifluoroacetic acid (TFA).
A compliant dsip coa details the UV detection chromatogram recorded at 214 nm or 280 nm. Purity is calculated by integrating the area under the curve (AUC) for all detected peaks. The main chromatographic peak corresponding to intact DSIP must constitute greater than 99% of the total integrated area. Minor secondary peaks representing baseline noise or micro-impurities must remain below institutional thresholds to prevent non-specific receptor binding or skewed biochemical data during sensitive in vitro assays evaluated across our research peptides catalog.
Bacterial endotoxins—lipopolysaccharides (LPS) derived from the outer membrane of Gram-negative bacteria—pose a significant confounding variable in cell culture models, isolated tissue preparations, and preclinical animal studies. Exposure to exogenous endotoxins can trigger pro-inflammatory cytokine cascades, masking the intrinsic biological effects of the compound under evaluation.
PX1 Research enforces stringent bio-burden controls during the manufacturing and lyophilization of DSIP 60mg. Every lot undergoes quantitative LAL testing to confirm endotoxin levels fall strictly below 0.01 EU/μg of peptide. This rigorous threshold ensures that observed experimental outcomes—such as altered central nervous system firing rates or endocrine shifts—are strictly attributable to the peptide mechanism rather than immune system activation from pyrogenic contaminants.
Delta-Sleep-Inducing Peptide was originally isolated from the hemodialysate of rabbits subjected to electrical stimulation of the thalamic somnogenic zone. Subsequent structural analysis revealed an amphiphilic nonapeptide structure that readily crosses the blood-brain barrier via passive diffusion and carrier-mediated transport mechanisms.
Preclinical electroencephalographic (EEG) studies in rodent models demonstrate that DSIP administration promotes slow-wave delta sleep (0.5–4 Hz) activity without disrupting normal REM architecture. Pharmacological studies suggest that DSIP modulates central neurotransmission through multiple pathways, including the inhibition of baseline hypothalamic-pituitary-adrenal (HPA) axis hyperreactivity. By attenuating stress-induced adrenocorticotropic hormone (ACTH) and corticosterone secretion, DSIP facilitates physiological recovery states during rest. Furthermore, in vitro neuronal culture assays indicate that DSIP exerts neuroprotective effects by decreasing NMDA receptor-mediated excitotoxicity and suppressing lipid peroxidation under hypoxic conditions.
When designing protocols to investigate neuroendocrine regulation, stress-axis modulation, or circadian rhythms, researchers frequently compare DSIP to other synthetic regulatory peptides. Each compound exhibits distinct molecular targets and physiological mechanisms within preclinical model systems:
While DSIP primarily targets central sleep architecture and HPA axis recovery, the synthetic pineal tetrapeptide epithalon acts on telomerase expression and melatonin secretion pathways to regulate cellular senescence. Similarly, the synthetic heptapeptide selank and its analogue semax act predominantly as neuroprotective neuromodulators, altering brain-derived neurotrophic factor (BDNF) expression and GABAergic transmission without direct sleep-inducing properties. Comparing these distinct mechanisms allows laboratory teams to select the exact biological driver required for their specific neurochemical models.
Proper reconstitution technique is crucial to maintain the structural integrity of lyophilized DSIP and prevent aggregation or peptide degradation. Research personnel should conduct all liquid handling procedures inside a certified laminar flow hood utilizing sterile, pyrogen-free laboratory consumables.
To reconstitute a 60mg vial of DSIP, slowly introduce sterile bacteriostatic water (containing 0.9% benzyl alcohol) or sterile physiological saline down the inner glass wall of the vial. Direct stream pressure onto the lyophilized cake should be avoided to prevent mechanical shearing of the peptide chain. Allow the liquid to gently hydrate the powder cake for 5–10 minutes, followed by gentle swirl motion until full dissolution is achieved. In vortexing or violent agitation must be strictly avoided, as surface aeration can induce protein denaturation and insoluble aggregate formation.
Lyophilized DSIP powder exhibits high thermodynamic stability when stored under desiccated conditions at -20°C to -80°C, remaining stable for up to 24 months without significant degradation. Vials should be kept away from direct light exposure to prevent photo-oxidation of the tryptophan residue located at the N-terminus of the peptide sequence.
Once reconstituted into aqueous solution, DSIP exhibits a shorter stability window. Reconstituted aliquots stored at 2°C to 8°C should be utilized within 30 days. For long-term experimental series extending over several months, working solution aliquots should be frozen immediately at -80°C to prevent freeze-thaw degradation cycles. Repeat thermal cycling can cause peptide precipitation and reduced bioactivity in subsequent cell culture or receptor binding assays.
For academic institutions, pharmaceutical development laboratories, and high-throughput screening facilities, supply chain consistency and lot-to-lot reproducibility are critical. PX1 Research manufactures all peptide sequences in USA-based, GMP-compliant facilities utilizing advanced solid-phase peptide synthesis technologies.
Principal investigators requiring large material volumes can establish a wholesale lab account to access bulk inventory quantities, custom vial configurations, and dedicated quality control packets. Every order dispatched from our California and Arizona logistics hubs includes lot-traceable COA documentation, supported by same-day shipping (Monday through Friday) to eliminate trial downtime and maintain laboratory workflow continuity.
What is a dsip coa and why is it necessary for laboratory research?
A DSIP COA (Certificate of Analysis) is a third-party analytical document verifying the identity, optical purity, mass spectrometry confirmation, and endotoxin levels of a specific batch of Delta-Sleep-Inducing Peptide. It ensures researchers receive unadulterated, highly pure material suitable for quantitative in vitro and preclinical studies.
How do I interpret a dsip-coa analytical report?
When reviewing a dsip-coa, verify that the HPLC purity peak constitutes >99% of the total integrated area, check that the mass spectrometry peak matches the expected molecular weight of 848.81 Da, and confirm that the LAL endotoxin assay reports levels below 0.01 EU/μg.
What HPLC purity level is required for research-grade DSIP 60mg?
Research-grade DSIP 60mg requires a minimum RP-HPLC purity threshold of 98%, with premium PX1 Research batches routinely exceeding 99% purity to prevent baseline noise or non-specific binding during assays.
What theoretical molecular weight should appear on a DSIP mass spec report?
The theoretical molecular weight for Delta-Sleep-Inducing Peptide (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) is 848.81 g/mol. Mass spectrometry reports should show an observed mass peak corresponding to this exact molecular weight.
How does PX1 Research perform endotoxin testing on DSIP batches?
PX1 Research utilizes standardized Limulus Amebocyte Lysate (LAL) chromogenic assays in accordance with USP <85> guidelines to quantify endotoxin levels, ensuring every batch contains less than 0.01 EU/μg.
What diluent should be used to reconstitute lyophilized DSIP 60mg for laboratory assays?
Lyophilized DSIP 60mg should be reconstituted using sterile bacteriostatic water (0.9% benzyl alcohol) for multi-use laboratory storage or sterile physiological saline (0.9% NaCl) for immediate single-use cell culture assays.
How should reconstituted DSIP solutions be stored long-term?
Reconstituted DSIP solutions should be stored at 2°C to 8°C for short-term use (up to 30 days) or divided into single-use aliquots and frozen at -80°C to prevent freeze-thaw degradation over extended periods.
What mechanisms of action are evaluated in preclinical DSIP sleep studies?
Preclinical studies investigate DSIP for its ability to induce slow-wave delta EEG activity, modulate HPA axis hyperreactivity, lower systemic corticosterone release, and protect central neurons against oxidative stress.
How does DSIP compare to other neuroendocrine peptides like Epithalon or Selank?
While DSIP specifically targets delta-wave sleep induction and HPA stress axis recovery, Epithalon acts on pineal gland function and telomerase activity, whereas Selank acts as a neuroprotective neuromodulator affecting BDNF expression.
Can research institutions request bulk quotes with matching lot COAs?
Yes, academic and industrial laboratories can open a wholesale lab account with PX1 Research to secure bulk orders of DSIP 60mg accompanied by full lot-specific COA packages and custom analytical validation.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.